Showing results (21-30 of 681) with videos related to

Sort By:
Pageof 69
Drug News & Perspectives|June 14, 2003
Potential of modulatory cytokines in the rheumatoid arthritis processE Lubberts, W B van den Berg
Bailliere'S Best Practice & Research. Clinical Rheumatology|February 1, 2000
Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-IW B van den Berg, B Bresnihan
Nature Reviews. Rheumatology|October 3, 2009
IL-17 as a future therapeutic target for rheumatoid arthritisWim B van den Berg, Pierre Miossec
Tijdschrift Voor Psychiatrie|October 26, 2016
[The willingness of the Dutch to pay for mental health care]F R M Portrait, B van den Berg
Clinical and Experimental Immunology|November 17, 2009
Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?M I Koenders, W B van den Berg
Seminars in Arthritis and Rheumatism|October 26, 2013
Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeuticsWim B van den Berg, Iain B McInnes
Drug Design, Development and Therapy|July 23, 2016
Secukinumab for rheumatology: development and its potential place in therapyMarije I Koenders, Wim B van den Berg
Trends in Pharmacological Sciences|March 4, 2015
Novel therapeutic targets in rheumatoid arthritisMarije I Koenders, Wim B van den Berg
Pageof 69